In addition, mRNA expression levels of NLRP3, ASC, caspase-1, pro-IL-1β, and pro-IL-18 are upregulated in the liver of NASH patients compared to healthy controls [10,13]. The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatohepatitis.